New equipment for new-look Italy?:
This article was originally published in Clinica
Italian healthcare managers will invest more in up-to-date medical equipment as a result of healthcare reforms. With the sector increasingly driven by market forces, survival will depend on hospitals' ability to attract customers. Patients will favour prompt diagnosis with state-of-the-art equipment and those centres that do not offer it, whether in the private or public sector, will be forced to close. This is the thrust of a recent comment in Il Sole-24 Ore. It stops short, however, of explaining where the money for such investment will come from.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
HBW Market News: FTC Ends Another Supplement Scam, Australia Win For ChromaDex, GOED Report, Herbalife
Herbalife opens 9,200 square-foot training facility in China; GOED's latest annual market report, covering 2017-2018, is available; ChromaDex has two-tear exclusivity for nicotinamide riboside chloride in Australia; and A.S. Research arthritis claims for Synovia end in FTC settlement.
Pharma sells the rights to Germany’s Cheplapharm, which obtained EU/Russia rights in October. Cerecor will acquire Aevi Genomics for $16.1m plus contingent value rights.